{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:37:54Z","timestamp":1758807474521},"reference-count":26,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T00:00:00Z","timestamp":1127174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bipolar Disorders"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:p><jats:bold>Objectives:\u2002<\/jats:bold> In clinical practice patients with severe mania (agitation, insomnia and aggressive behaviour) still receive effective, but often not well tolerated typical antipsychotics. The aim of this study was to test the first\u2010generation atypical antipsychotic zotepine regarding its antimanic efficacy, tolerability and to find an adequate dosage for a loading strategy.<\/jats:p><jats:p><jats:bold>Method:\u2002<\/jats:bold> Twelve patients (seven male) with an acute and severe manic episode, according to DSM\u2010IV, received zotepine loading in individual dosages (up to 600\u2003mg\/day) over a maximum period of 3\u2003weeks. Clinical efficacy was measured using the Young\u2010Mania Rating Scale (Y\u2010MRS) total score. Response was defined as a 50% reduction in the Y\u2010MRS score. Safety was assessed by systematic collection of data on side effects and weight; Hamilton Rating Scale for Depression (HAM\u2010D) scores were used to detect a switch into depression.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Two patients dropped out of the study after 2\u2003days. Nine of ten patients (baseline mean Y\u2010MRS: 45\u2003\u00b1\u20037) were classified as responders, with five of them responding within 4\u2003days. One patient did not respond sufficiently. No switch into a depressive episode occurred.<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> This open pilot study suggests that zotepine with a median daily dosage of 250\u2003mg\/day is effective with a rapid therapeutic effect in severely manic patients. In general, patients tolerated the drug well; dose\u2010dependent extrapyramidal side effects, an increase in weight and autonomic side effects occurred to a lesser degree. This is the first study assessing zotepine monotherapy in manic patients. Controlled studies are warranted.<\/jats:p>","DOI":"10.1111\/j.1399-5618.2005.00241.x","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T10:47:40Z","timestamp":1127213260000},"page":"471-476","source":"Crossref","is-referenced-by-count":15,"title":["Zotepine loading in acute and severely manic patients: a pilot study"],"prefix":"10.1111","volume":"7","author":[{"given":"Benedikt","family":"Amann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Sterr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Mergl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Dittmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Seem\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Dobmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Orth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Grunze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,9,20]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510360044034"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000380"},{"key":"e_1_2_6_4_2","first-page":"153","article-title":"Rational polypharmacy in the bipolar affective disorders","volume":"11","author":"Post RM","year":"1999","journal-title":"Epilepsy Res Suppl"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.7.1263"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.57.9.841"},{"key":"e_1_2_6_7_2","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group","volume":"156","author":"Tohen M","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-200307000-00005"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(03)92033-5"},{"key":"e_1_2_6_10_2","volume-title":"Psychiatric Measures","author":"Rush AJ","year":"2000"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0116"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.145.11.1455"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1986.01800040052008"},{"key":"e_1_2_6_14_2","first-page":"70","article-title":"Zotepine \u2013 an antipsychotic with atypical profile","volume":"2","author":"M\u00f6ller HJ","year":"2000","journal-title":"PPT"},{"key":"e_1_2_6_15_2","first-page":"81","article-title":"A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel\u2010group double\u2010blind trial","volume":"32","author":"Petit M","year":"1996","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_6_16_2","first-page":"406","article-title":"Antimanic effect of zotepine","volume":"8","author":"Harada T","year":"1986","journal-title":"Clin Ther"},{"key":"e_1_2_6_17_2","volume-title":"Diagnostic and Statistical Manual of Mental Disorder","author":"American Psychiatric Association","year":"1994"},{"key":"e_1_2_6_18_2","volume-title":"Structured Clinical Interview for DSM\u2010IV (SCID)","author":"First MB","year":"1995"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.133.5.429"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.2044-8260.1967.tb00530.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-1781(97)00123-6"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(02)80574-0"},{"key":"e_1_2_6_23_2","first-page":"1079","volume-title":"Arch Gen Psychiatry","author":"Tohen M","year":"2003"},{"issue":"1","key":"e_1_2_6_24_2","first-page":"30","article-title":"Clinical efficacy of zotepine in the treatment of schizophrenic negative symptoms","volume":"59","author":"Mueller\u2010Spahn F","year":"1991","journal-title":"Fortschr Neurol Psychiatr"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199200710-00003"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2000.101003218.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000452"}],"container-title":["Bipolar Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-5618.2005.00241.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-5618.2005.00241.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T15:55:09Z","timestamp":1696866909000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-5618.2005.00241.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9,20]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1111\/j.1399-5618.2005.00241.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-5618.2005.00241.x","archive":["Portico"],"relation":{},"ISSN":["1398-5647","1399-5618"],"issn-type":[{"value":"1398-5647","type":"print"},{"value":"1399-5618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,9,20]]}}}